Background: An accurate, minimally invasive, ante-mortem diagnostic test for equine grass sickness (EGS) is currently lacking. Although histological examination of haematoxylin and eosin-stained rectal biopsies for chromatolytic neurons is insensitive as a diagnostic test for EGS, we hypothesised that its diagnostic accuracy could be improved by immunolabelling for b-amyloid precursor protein (b-APP), which has increased expression in cranial cervical ganglia (CCG) neuronal perikarya in EGS. Objectives: To develop a grading scheme for assessing the distribution and intensity of b-APP immunoreactivity within individual rectal submucosal neurons and subsequently to determine the value of the distribution of different grades of neurons in EGS diagnosis. Study design: Retrospective case-control diagnostic accuracy study. Methods: Initially, a standardised grading scheme was developed and b-APP immunoreactivity in individual neuronal perikarya and axons was compared in sections of CCG and ileum from EGS and control horses. The grading scheme was then refined before being blindly applied to submucosal neurons in rectal biopsies derived from 21 EGS and 23 control horses. Results: b-APP immunoreactivity was increased in neuronal perikarya and axons in sections of CCG, ileum and rectum from EGS horses compared with controls. For rectal biopsies, a mean immunoreactivity grade exceeding 1.1 was 100% specific and sensitive for EGS, and the presence of at least one neuron with diffuse labelling of the entire cytoplasm (grade 3) was 95% sensitive and 100% specific for EGS. Main limitations: Although the diagnostic criteria facilitated the discrimination of the EGS and control biopsies evaluated in this study, further prospective validation using a larger sample set is required. Conclusions: Histological assessment of b-APP immunolabelled rectal biopsies is more sensitive than conventional histological examination in EGS diagnosis. Further validation is required before this technique can be advocated for use in clinical decision making.
Introduction
A sensitive, minimally invasive, ante-mortem diagnostic test for equine grass sickness (EGS) is currently lacking. Such a test would facilitate appropriate case management by aiding EGS diagnosis, which is currently challenging in some cases, and avoid the necessity for invasive ileal biopsy. The presence of chromatolytic neurons in rectal submucosa of EGS horses [1] [2] [3] [4] indicates that histological assessment of rectal biopsies could potentially provide a relatively simple, minimally invasive and inexpensive ante-mortem diagnostic technique. Histological examination of two fullthickness, haematoxylin and eosin (H&E)-stained sections of rectum collected post-mortem yielded sensitivity of 71% and specificity of 100% for EGS diagnosis when the diagnostic criterion was the identification (21% sensitivity) of at least three chromatolytic neurons [3] . However, a later study found that histological examination for chromatolytic neurons in H&E-stained rectal biopsy sections is insensitive for EGS diagnosis [4] . The diagnostic value of rectal biopsies in EGS diagnosis is potentially limited by small sample size, the paucity of neurons in rectal submucosal plexi, difficulty in histological recognition of chromatolytic neurons, and crush artefacts. It was suggested that the application of specific neuronal labelling may overcome some of these limitations and thereby increase the technique's diagnostic utility [4] . Although synaptophysin immunolabelling of ileal sections facilitates correct differentiation of control and EGS cases [5] , synaptophysin immunolabelling of rectal sections provides no further diagnostic sensitivity compared with H&E-stained rectal sections (E. M. Milne, unpublished data, 2010 ).
This study tested the hypothesis that immunolabelling with b-amyloid precursor protein (b-APP), which accumulates in cranial cervical ganglia (CCG) neuronal perikarya in EGS [6] , would improve the accuracy of histological assessment of rectal biopsies in the diagnosis of EGS. b-amyloid precursor protein is an extensively post-translationally modified and proteolytically cleaved transmembrane protein, associated with synaptic formation and repair, that is present at high concentrations within neurons [7] . Increased b-APP expression is part of the acute phase response to neuronal injury [8] , occurring in acquired diseases [9, 10] , in various neurodegenerative conditions [11] including Alzheimer's disease [12] , in Down's syndrome [13] and tauopathies [14] , and in murine neurodegenerative disease models [15] . The expression of b-APP is therefore not specific for EGS.
The purpose of this study was to develop and refine a grading scheme for assessing the distribution and intensity of b-APP immunoreactivity within individual neuronal perikarya and axons in rectal biopsies and subsequently to determine the best diagnostic predictor for discriminating between EGS and control horses. Initially, sections of ileum and CCG were utilised to establish a grading scheme for assessing b-APP immunoreactivity prior to evaluating the rectal submucosal plexi, which has fewer neurons [1, 2] . Neuronal pathology is not uniform throughout the gastrointestinal tract in EGS, and the ileum has been reported consistently to be the most severely affected region [1, 2, 16] . Histopathological examination of formalin-fixed, H&E-stained CCG is regarded as the reference standard diagnostic test for EGS [2, 17, 18] , and histopathological examination of formalin-fixed, H&E-stained ileal sections offers up to 100% sensitivity and specificity [16] .
Materials and methods

Collection of tissue samples
Tissue samples were collected ante-mortem from EGS and control horses for routine clinical diagnostic purposes or, with the horse owners' consent, post-mortem from horses subjected to euthanasia. All ileal [19] , CCG [6, 19] and some EGS rectal biopsies [4] were available from previously reported studies. All the control and remaining EGS rectal biopsies were collected prospectively. Horses were of mixed breeds and sex. EGS was confirmed by post-mortem examination, including conventional histopathological examination of H&E-stained CCG and/or ileum [2, [16] [17] [18] 20, 21] , by specialist pathologists experienced in EGS diagnosis. EGS was categorised as previously described [22, 23] . In summary, acute EGS cases had mild to moderate abdominal pain with gastric and small intestine distension; subacute EGS cases had less severe signs, a more insidious onset and secondary large intestine impactions, and chronic cases had none of these sequelae. In all control cases with colic, a physical lesion was identified at exploratory laparotomy. All other control horses had no ante-mortem clinical evidence of EGS and had been subjected to euthanasia for unrelated reasons. The median age of 5 years reported for EGS horses [24] was considered when selecting cases for control rectal biopsies so that there would be no significant intergroup difference in age. CCG and fullthickness ileal samples were collected post-mortem within 3.5 h of death. Rectal biopsies were collected using Equivet uterine biopsy forceps a [4] . Post-mortem rectal biopsies were collected within 10 min of death. Tissues were fixed in 10% neutral buffered formalin and embedded in paraffin wax, after which 4-lm sections were cut. A single section from each rectal biopsy contributed to a single histology slide for each horse.
Immunohistochemistry
Immunohistochemistry was carried out as previously reported [6] and as detailed in Supplementary Item 1.
Grading of neuronal and axonal immunolabelling
Cranial cervical ganglion and ileum: See Supplementary Item 2.
Rectum: Preliminary screening of rectal samples indicated that the grading scheme developed using the CCG and ileal sections was insufficiently precise to facilitate repeatable grading of the immunolabelling of individual neurons, and in particular to differentiate grade 2 and grade 3 neurons. Further refinement of the grading scheme to facilitate repeatable assessment of the intensity and distribution of immunolabelling of individual neurons was achieved by detailed assessment of the immunolabelling of individual neurons in a randomly selected subset of rectal sections, with no regard to disease status. When applying the refined grading scheme, grade 3 neurons, by contrast with grade 2 neurons, were classified as those with diffuse labelling of the entire cytoplasm, extending right up to the perikaryonal margin, except when this was displaced by cytoplasmic vacuolation (Fig 1) . This grading system was then applied by a single observer (RCJ) in the blinded assessment of all rectal biopsy sections. In all sections, all submucosal plexus neurons containing nuclei were graded. Neurons were identified using a 910 objective and individual neurons were graded using a 940 objective.
All rectal biopsy sections were blindly assessed on a second occasion by the same observer (RCJ) and by a specialist in veterinary pathology (SS) to assess intra-and inter-observer agreement, respectively, and to determine the repeatability of the proposed grading scheme.
Data analysis
Age, number of rectal biopsies per horse and number of neurons counted per horse were described as the median and interquartile range (IQR). For each horse, the distribution of different grades of neuron was determined and a mean immunoreactivity grade calculated. The Mann-Whitney U test Grading scheme used to assess b-amyloid precursor protein immunolabelling of neuronal perikarya in rectal submucosal ganglia. Grade 0: no labelling (blue arrowheads); grade 1: sparse labelling involving less than half the cytoplasm (blue arrows); grade 2: over half the cytoplasm is labelled but areas of unlabelled cytoplasm are still discernible (black arrowhead); grade 3: diffuse labelling of the entire cytoplasm up to perikaryonal margin with no unlabelled cytoplasm discernible (black arrows). a) In a sample from a control horse, the majority of neurons are grade 0; the example of grade 1 labelling (blue arrow) was not included in the analysis as the nucleus of the neuron is not in the plane of the section. b) Examples of all immunolabelling grades are present in a sample from a horse with equine grass sickness (EGS). c) Immunolabelling of neurons varies from grades 1-3 in a sample from a horse with EGS; note that the grade 3 neuron has peripheral cytoplasmic vacuolation and a shrunken (pyknotic) nucleus compared with the other neurons in the ganglion. Scale bars: 10 lm.
Equine Veterinary Journal 50 (2018) 22-28 © 2017 EVJ Ltd was used for intergroup (control vs. EGS, ante-mortem vs. post-mortem sample collection, chronic vs. subacute vs. acute) comparisons of these variables. Using conventional histopathological examinations of H&E-stained CCG [2, 17, 18, 20] and ileum [16, 21] as the reference tests for EGS diagnosis, the sensitivity and specificity of EGS diagnosis using histological assessment of b-APP immunoreactivity of rectal biopsies was calculated. The predictive value of the distribution of different grades of neurons and of the mean immunoreactivity grade for EGS diagnosis was determined by constructing receiver operating characteristic (ROC) curves and estimating the area under the curve (AUC). An optimal cut-off was proposed by identifying a point that would give maximum sensitivity with an estimated specificity of 1.0. A specificity of 1.0 was selected (i.e. no false positives within the study data) to minimise the possibility that a horse erroneously diagnosed with EGS would be inappropriately submitted to euthanasia. The number of neurons required for evaluation per horse in order to be confident that a grade 3 neuron was or was not present, at the expected median prevalence, was calculated using a surveillance design tool b . The total estimated number of neurons within the rectum required for this calculation was calculated assuming that neuronal density is uniform throughout the length of the rectum [2] , the diameter of submucosal neuronal perikarya is 25 lm, and rectal length and diameter are 30 cm and 7 cm, respectively [25] . Using the presence of at least one grade 3 rectal neuron as the criterion for EGS diagnosis, kappa statistics were calculated for intra-and inter-observer agreement in the interpretation of cases (EGS/control) using a diagnostic design tool b . GraphPad Prism 7 c was used for all statistical analyses, unless specifically stated otherwise. A P≤0.05 was used as the threshold for statistical significance. This study conformed to the Standards for the Reporting of Diagnostic Accuracy (STARD) guidelines where appropriate.
Results
CCG and ileal sections
See Supplementary Item 2.
Rectal biopsy sections
Rectal biopsies represented 21 horses with EGS (six with acute disease, 12 with subacute disease and three with chronic disease) and 23 control horses. Eight EGS samples were collected ante-mortem and the remainder post-mortem. Samples from two control horses (one with weight loss and one with chronic diarrhoea) were collected ante-mortem and the remainder post-mortem. Reasons for euthanasia in horses from which control material was collected post-mortem were associated with behavioural issues (n = 1), colic (n = 4), neurological issues (n = 4), recurrent uveitis (n = 1), and orthopaedic issues (n = 7). The remaining four horses from which control material was collected were elderly and donated for research purposes. There was no significant difference in age between the control and EGS horses from which rectal biopsies were collected (Supplementary Item 3).
All rectal biopsy sections comprised mucosa and submucosa with the submucosal plexus, but no myenteric plexus. Significantly more rectal biopsies were collected from controls (median: 4; IQR: 4-5) than from EGS horses (median: 2; IQR: 2-2), which resulted in the counting of a significantly higher total number of neurons in control sections (median: 187; IQR: 111-308) than in EGS sections (median: 70; IQR: 46-115). However, the average number of neurons per section did not differ significantly between EGS (median: 37; IQR: 23-58) and control (median: 46; IQR: 24-58) horses.
Horses with EGS had significantly lower percentages of grade 0 neurons and significantly higher percentages of grade 1, 2 and 3 neurons (Figs 1, 2, Table 1 ; Supplementary Item 4). Grade 3 neurons were not observed in control horses, but were observed in all but one EGS case. Very occasional adjacent nerve processes were labelled, but none were detected in the mucosa.
Although most EGS and control rectal sections could be readily differentiated based on the intensity and distribution of neuronal b-APP immunoreactivity using the criteria of >5% grade 3 neurons (EGS), >40% grade 0 neurons (control) and a high proportion of grade 2 neurons (EGS) (Fig 2) , a subpopulation of samples (n = 9 [Supplementary Item 4]) were considered to be equivocal. The equivocal cases included two controls with lower percentages of grade 0 neurons and higher percentages of grade 1 neurons compared with the other controls. Both these cases were sampled ante-mortem, in one case to investigate the cause of chronic diarrhoea and in the other to investigate weight loss. The seven equivocal EGS cases included one acute, three subacute and three chronic EGS cases with <4% grade 3 neurons. Although these cases would be equivocal in a clinical situation, there was no overlap in mean immunoreactivity grades of neurons in EGS and control horses, whereas the percentage of grade 1 neurons showed the greatest degree of overlap between EGS and control horses, and all other diagnostic determinants were similar (Table 1) . Consequently, the AUC of the ROC curves was highest for mean immunoreactivity grades (with a value of >1.1 indicative of EGS). When specificity was set at 1.0, the highest diagnostic sensitivity for EGS diagnosis was a mean immunoreactivity grade exceeding 1.1 (1.0 sensitivity) and a percentage of grade 3 neurons exceeding 0.75% (0.95 sensitivity). Use of the presence of at least one neuron with diffuse labelling of the entire cytoplasm (grade 3) in a rectal biopsy as the criterion for EGS diagnosis yielded sensitivity of 95% and specificity of 100% in the diagnosis of EGS.
Mean immunoreactivity grade did not differ significantly (P = 0.09) between EGS samples collected ante-mortem (median: 2.03; IQR: 1.46-2.62) and samples collected post-mortem (median: 1.58; IQR: 1.22-1.84). No further analyses were performed in control samples because only two were collected ante-mortem. The median number of total neurons per section was higher in chronic cases (median: 60; IQR: 27-70) than in acute and subacute cases (median: 34; IQR: 23-49); however, the difference was not significant.
The median prevalence of grade 3 neurons in EGS horses was 11.4% (Table 1 ). The total estimated population of submucosal neurons that could be biopsied within the rectum was 23-46 million per horse, depending on whether each nucleus was in one or two adjacent sections. If the total population of submucosal neurons that could be sampled by a rectal biopsy is >5000, grading of at least 30 neurons would be required to have 96% confidence that a grade 3 neuron was or was not present at the expected median prevalence of 11.4% (20 neurons: 89% confidence; 50 neurons: 99.6% confidence).
The kappa statistics were 1.0 (95% confidence interval [CI] 1.0-1.0) and 0.95 (95% CI 0.87-1.04) for intra-and inter-observer agreement, respectively, in the interpretation of each case.
Non-neuronal labelling and artefacts
Intimal asteroid bodies [26] were unlabelled in the antibody-negative method control sections, but were immunopositive in antibody-positive sections (Fig 3a) . This labelling was readily differentiated from positive neuronal labelling because of their location, protrusion into the lumen of small arterioles and lack of nucleus. Pigment granules (haemosiderin and/or lipofuscin) within macrophages were evident in the submucosa of some horses, and could be distinguished from immunolabelling by the characteristics of the pigment, presence in corresponding control sections and characteristics of cell morphology (Fig 3b) . Oval particles of plant debris were occasionally translocated from the lumen during the biopsy procedure and could readily be differentiated by morphological characteristics including the absence of nuclei (Fig 3c) .
Discussion b-Amyloid precursor protein immunoreactivity was increased in neuronal perikarya and axons in sections of the CCG, ileum and rectum from EGS horses compared with controls. These data extend previous findings of increased b-APP immunoreactivity in CCG sections and increased expression of b-APP in CCG protein extracts in EGS [6] . b-Amyloid precursor protein is synthesised in the endoplasmic reticulum and transported through the Golgi apparatus, plasma membrane and axons [7] . The pattern of labelling observed in control rectal submucosal neurons (Fig 1: grade 1) is consistent with this normal cellular processing of b-APP, and is similar to that observed in other neuronal populations. By contrast, some neurons in EGS horses had intense granular to diffuse labelling throughout the cytoplasm (Fig 1) , indicating abnormal accumulation of b-APP; consistent with dysfunction and degradation of membrane-bound compartments. This study confirms previous work [6] showing that EGS is associated with the accumulation of b-APP in the perikarya of degenerate neurons, in adjacent nerve processes and in intraganglionic axons, but not in larger nerve fascicles. Potentially this may reflect: 1) upregulation of neuronal synthesis of these proteins; 2) reduced catabolism of b-APP; 3) dysfunction of glycoprotein processing in the Golgi network; and/or 4) failure of axonal transport of protein-containing vesicles to the nerve terminal. Accumulation of b-APP in the perikarya and intraganglionic axons, but not in larger nerve fascicles, is consistent with the last of these options. Consistent with the latter two hypotheses, ultrastructural loss of a recognisable Golgi structure is a likely early event in EGS, and EGS is associated with major perturbations in the cytoskeleton of autonomic neurons that result in the accumulation of dopamineb-hydroxylase and presynaptic proteins in neuronal perikarya [19, 27, 28] . b-APP has been described as a marker of early axonal injury prior to apparent histological changes in routine H&E-stained sections [29] .
Evaluation of b-APP immunolabelled rectal biopsy sections using a standardised grading scheme can aid in the diagnosis of EGS. Indeed, for the sections evaluated in this study, a mean immunoreactivity grade exceeding 1.1 was 100% specific and sensitive for EGS, and the presence of at least one neuron with diffuse labelling of the entire cytoplasm (grade 3) was 95% sensitive and 100% specific for EGS. This diagnostic accuracy is comparable with that of conventional histological examination of ileal biopsies [16, 21] , which has sensitivity and specificity of 100% [16] , and thus is significantly more accurate than conventional histological examination of two rectal biopsies (sensitivity 21%) [4] . However, further validation of this technique is required prior to its application in clinical contexts.
A subset of CCG, ileal and rectal biopsy samples were pre-screened in order to establish grading schemes and to identify non-neuronal staining, prior to blinded evaluation. Individual neuronal perikarya and axons were used as examples of b-APP immunolabelled neurons to facilitate the development and refinement of the grading schemes, with absolutely no bearing on whether the neurons were derived from control or EGS sections. The grading scheme was then applied blindly to determine which grading parameter had the greatest diagnostic accuracy in discriminating EGS and control sections.
A limitation of the study was that although the diagnostic criteria facilitated differentiation of EGS and control rectal samples in this sample set, both the grading scheme and the diagnostic criteria require further development and prospective validation using larger numbers of EGS and control samples before the diagnostic value of this approach can be fully advocated.
Although the subpopulation of equivocal samples would have been correctly classified using the criterion of a mean immunoreactivity grade exceeding 1.1, their assessment in a clinical context would involve a degree of uncertainty. Consequently, the use of these criteria in a clinical situation would reduce confidence in a diagnosis based solely on this diagnostic approach. This is a significant consideration in light of the fact that a false positive result might prompt the euthanasia of a horse without EGS. It is important to note that these samples would have been highlighted as equivocal and not erroneously diagnosed. Further work is required to optimise differentiation of the equivocal subpopulation of samples. Although a mean immunoreactivity grade exceeding 1.1 was 100% specific and sensitive for EGS, there are limitations to the use of this criterion in the diagnosis of EGS. Firstly, there was very little difference between the highest mean immunoreactivity grade in control horses (1.057) and the lowest mean immunoreactivity grade in EGS horses (1.137) (Supplementary  Item 4) ; consequently, it is possible that this criterion may not be fully discriminatory when a larger sample size is prospectively evaluated. Further limitations of this criterion are that it is laborious to determine and is likely to be subject to a degree of inter-observer variability.
Similarly, although the presence of at least one grade 3 neuron was 95% sensitive and 100% specific for EGS, use of this criterion is potentially limited by errors in differentiating grade 2 and grade 3 neurons. To reduce this error, very repeatable grading criteria were applied, such that grade 3 neurons had diffuse labelling of the entire cytoplasm, extending right up to the perikaryonal margin, except when this was displaced by cytoplasmic vacuolation (Fig 1) . This potential limitation is confounded by the relative paucity of grade 3 neurons in rectal biopsies of EGS cases (median: 11.4% of neurons; IQR: 2.8-42%) compared with CCG (median: 35.5%; IQR: 21-41%). Consequently, EGS diagnosis was based on the presence of only a few grade 3 neurons, and in occasional cases on only one grade 3 neuron (in two horses). Chromatolytic neurons have been reported in the coeliacomesenteric ganglia, jejunum, ileum and small colon in clinically normal horses [2] . Although the assessment of chromatolysis is subjective, and relatively objective immunolabelling grading criteria may reduce the likelihood of the incorrect classification of neurons, a larger sample size is required to determine if grade 3 neurons are ever present in control horses. Although increasing the threshold for the diagnosis of EGS to the TABLE 1: Diagnostic determinants with associated areas under the receiver operating characteristic curve (AUC), and highest achievable sensitivity, when specificity is set at 1.0, and the thresholds set to achieve this, for the diagnosis of equine grass sickness (EGS) Cranial cervical ganglia, ileal and rectal neurons from EGS horses, but not control horses, had pyknotic nuclei (Fig 1c) . Further study is required to determine whether this conventional histopathological analysis for morphological features of neurodegeneration, together with chromatolysis and neuronal swelling, could be incorporated into the grading scheme to improve the diagnostic accuracy of rectal biopsies.
There was complete intra-observer and very good inter-observer agreement in the interpretation of cases. The single case that resulted in disagreement was an equivocal EGS case in which only one grade 3 neuron was observed. In a clinical situation, it is unlikely that a diagnosis of EGS would be based upon the observation of a single grade 3 neuron, and further criteria or the assessment of additional sections are required to give greater confidence in differentiating the equivocal subpopulation of samples.
Further work is required to assess the effect of EGS category on neuronal b-APP immunoreactivity. Consistent with previous work [1, 2, 17, 18] , higher proportions of normal neurons were found in chronic cases: all three sections from horses with chronic EGS showed significantly fewer grade 3 rectal neurons than those from acute and subacute cases. In line with the findings of a further study [2] , the median number of total neurons per section was higher in chronic cases than in acute and subacute cases; however, the difference was not statistically significant and data from more chronic cases should be assessed to further investigate these findings. Acute and subacute forms of the disease are invariably fatal, whereas some animals with chronic EGS survive with appropriate nursing [24, [30] [31] [32] [33] . A larger dataset of chronic cases is required to investigate the potential prognostic value of b-APP immunolabelling.
Although estimations indicate that at least 30 neurons must be examined to be 96% confident that a grade 3 neuron is or is not present, at the expected median prevalence of 11.4%, it is likely that the diagnostic value of rectal biopsies and confidence in the diagnosis could be improved by increasing the number of biopsies collected from each horse and by examining multiple nonserial sections cut from individual biopsies. Previous studies indicate that the density of submucosal neurons does not have a consistent circumferential pattern in rectal samples [3] , indicating that collection of biopsies from specific locations around the circumference of the rectal wall cannot reliably maximise the number of neurons sampled. Although the total number of neurons identified in control rectal cases exceeded that of EGS cases, this reflected the increased number of biopsies collected from controls. Consequently, there was no intergroup difference in the median number of neurons per section. The median number of rectal biopsies collected from EGS horses was comparable with that in a previous study by Mair et al. [4] . More biopsies were collected from control horses to increase confidence in the calculated specificities.
The effects of ante-mortem vs. post-mortem sampling must be further evaluated. Both of the control samples collected ante-mortem had lower percentages of grade 0 neurons and were the only control cases that were classified as equivocal. Although there was a difference of 0.45 in median mean immunoreactivity grade between EGS samples collected ante-and post-mortem, respectively, this difference was not significant.
The use of relatively noninvasive rectal biopsies vs. ileal biopsies collected at laparotomy to diagnose EGS offers economic, welfare and time benefits. A disadvantage is the increased time required for immunolabelling of rectal biopsies compared with H&E staining of ileal biopsies: minimum total sample fixing and processing times are, respectively, 12 h and 6 h. The timescale may be appropriate for the antemortem diagnosis of subacute and chronic EGS cases and for the postmortem confirmation of EGS in horses that have been subjected to euthanasia in the field when the invasive removal of CCG or ileum is not feasible. However, this technique may be unsuitable for rapid ante-mortem diagnosis of acute EGS unless the time requirement can be reduced, perhaps by using accelerated fixation protocols and frozen sections, and employing rapid immunolabelling techniques.
In conclusion, this work has demonstrated the potential diagnostic value of immunolabelled rectal biopsies in the diagnosis of EGS. However, further prospective studies are required before the use of this technique can be fully advocated in clinical decision making.
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